30 Jan
Ecosystem Innovation

We started 2024 by supporting the entrepreneurial ecosystem at Science 4 Industry and the Ship2B Foundation Demo Day

In January, Cinfa actively participated in two significant events through CinfaNext. These events aimed to foster the entrepreneurial ecosystem, establish connections with emerging talent, and explore new opportunities for collaboration.

The closing Demo Day for the 15th edition of the acceleration and funding programs, S2B Health&Care and S2B Tech4Climate, organised by the Ship2B Foundation, was held on January 18th at the ONCE Foundation facilities. This event provided a platform for the eight participating impact startups to present their proposals to members of the funding network, company representatives, mentors from the Foundation’s network, and other ecosystem stakeholders. 

As partners of S2B Health&Care, CinfaNext would like to congratulate all the participants for their hard work and effort. The winning startup on this occasion was FlowReserve Labs, which focuses on providing cardiology indicators of personalised medicine based on the reconstruction of AngioCAT images for the diagnosis, monitoring and treatment planning of patients with ischaemic heart disease.

Additionally, this month, we attended Science 4 Industry (S4i), a marquee event in the field of deep science. S4i focuses on connecting startups, corporations, and investment entities, while also bringing together international leaders and experts in the industry to foster the open innovation ecosystem in Spain. The second edition of this event, organised by Universidad Autónoma de Madrid (UAM) and fund manager BeAble Capital, was held on January 18th and 19th at the Nave de Madrid. 

This meeting has become an unmissable event in the calendar of scientific start-ups seeking both investment and a closer link with the innovation programs of large companies such as Acciona, Repsol or Cinfa. Companies, universities and research centres had the opportunity to get in touch with different institutions such as the European Commission, the European Investment Fund, the European Investment Bank and different European science equity funds to make connections that enable technological and industrial progress. 

In collaboration with other organisations in the healthcare ecosystem such as Sanitas, the Pfizer Foundation and Exeltis, we actively liaised with the various projects participating in this edition. We discussed the potential of these projects, and exchanged numerous ideas.